Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial (EDIT-CMD)
Sponsor: Radboud University Medical Center
A PHASE3 clinical study on Coronary Vasospasm and Microvascular Angina, this trial is ongoing. The trial is conducted by Radboud University Medical Center and has accumulated 5 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Apr 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Mar 2022 — Apr 2023 [monthly]
Recruiting PHASE3
-
Apr 2021 — Mar 2022 [monthly]
Recruiting PHASE3
First recorded
Oct 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Radboud University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .